tkirkman, Author at Cerus Corporate Site

Cerus Websites

Team Work and Communications in the Age of Covid

by tkirkman | Oct 9, 2020 | Insights Blog

Insights: A Cerus Leadership Blog TEAMWORK AND COMMUNICATIONS IN THE AGE OF COVID Lori L. Roll, VP Administration at CerusWe caught up with Lori Roll, Cerus’ VP of Administration this week to discuss the importance of collaboration, leading during a pandemic and the...

Next Entries »

About Cerus

Cerus Corporation is dedicated solely to safeguarding the world’s blood supply and aims to become the preeminent global blood products company. Headquartered in Concord, California, the company develops and supplies vital technologies and pathogen-protected blood components to blood centers, hospitals, and ultimately patients who rely on safe blood. The INTERCEPT Blood System for platelets and plasma is available globally and remains the only pathogen reduction system with both CE Mark and FDA approval for these two blood components. The INTERCEPT red blood cell system is under regulatory review in Europe, and in late-stage clinical development in the US. Also in the US, the INTERCEPT Blood System of Cryoprecipitation is approved for the production of Pathogen Reduced Cryoprecipitated Fibrinogen Complex (commonly referred to as INTERCEPT Fibrinogen Complex), a therapeutic product for the treatment and control of bleeding, including massive hemorrhage, associated with fibrinogen deficiency. Follow us on LinkedIn.

Cerus.com

INTERCEPT-USA.com

HCP.INTERCEPT-USA.com

INTERCEPT-Canada.com

INTERCEPTBloodSystem.com

INTERCEPT-Cryoprecipitation.com

Team Work and Communications in the Age of Covid

Recent Posts

Recent Comments

About Cerus